.webp){kind=spacer}
The successful scaling of a bioconjugate requires precise coordination among three distinct supply chains: the monoclonal antibody, the payload-linker, and the final conjugation.
At Piramal Pharma Solutions, our integrated global network is built to manage this complexity. By aligning the distinct bioconjugate operations across our facilities, we conduct simple, safe, and fast tech transfers that eliminate friction and increase efficiency in our clients' programs.
Our approach relies on robust program management and expert technical and quality teams who oversee transitions to preserve integrity and ensure consistency as programs move across sites. By reducing handoffs and maintaining centralized visibility, we accelerate partner's timelines while safeguarding the quality of their products.
Operating within our integrated network doesn't just increase speed, it enhances supply chain resilience, too. Amid rising geopolitical tensions and regulatory changes in China, pharma developers have adopted a China Plus One risk-mitigation approach – a strategic imperative that protects companies from the supply chain risks associated with relying on a single country.
This approach is particularly important in bioconjugate development and manufacturing, where one setback can derail an entire program by conducting programs and tech transfers across our strategically located facilities in the U.S., UK, and India, we help partners derisk their supply chain, protect continuity, and maintain momentum from lab-scale to commercialization.
.jpg)
For nearly a decade, we've partnered with Pharmafreight for consistent, reliable logistics support for bioconjugate programs and tech transfers. While Pharmafreight provides specialized transportation services, our team maintains direct oversight of all inter-facility transfers to ensure alignment with our rigorous quality standards.
Pharmafreight's certifications include:
Our track record demonstrates consistency, reliability, and speed:
These results reflect the strength of our integrated infrastructure, meticulous program management approach, and precise logistics capabilities.
